Dry mouth: A critical topic for older adult patients

Journal of Prosthodontic Research

Volumn 59, Issue 1, 2015, Pages 6-19

  Han, Phuu ^a   Suarez Durall, Piedad ^a   Mulligan, Roseann ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Dry mouth; Older adults; Salivary gland hypofunction; Treatment; Xerostomia

Indexed keywords

AGED; COMPLICATION; COST BENEFIT ANALYSIS; HUMAN; PATIENT EDUCATION; RISK ASSESSMENT; SJOEGREN SYNDROME; VERY ELDERLY; XEROSTOMIA;

AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; HUMANS; PATIENT EDUCATION AS TOPIC; RISK ASSESSMENT; SJOGREN'S SYNDROME; XEROSTOMIA;

EID: 84920725416     PISSN: 18831958     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpor.2014.11.001     Document Type: Review

References (90)

1. Berkey D., Berg R. Geriatric oral health issues in the United States. Int Dent J 2001, 51:254-264.
2. Ezeh A.C., Bongaarts J., Mberu B. Global population trends and policy options. Lancet 2012, 380:142-148.
3. Branca S., Bennati E., Ferlito L., Spallina G., Cardillo E., Malaguarnera M., et al. The health-care in the extreme longevity. Arch Gerontol Geriatr 2009, 49:32-34.
4. Müller F., Naharro M., Carlsson G.E. What are the prevalence and incidence of tooth loss in the adult and elderly population in Europe?. Clin Oral Implants Res 2007, 18:2-14.
5. Ettinger R.L. Oral health and the aging population. J Am Dent Assoc 2007, 138:5S-6S.
6. Lee K.H., Wu B., Plassman B.L. Cognitive function and oral health-related quality of life in older adults. J Am Geriatr Soc 2013, 61:1602-1607.
7. Kane R.L., Shamliyan T., Talley K., Pacala J. The association between geriatric syndromes and survival. J Am Geriatr Soc 2012, 60:896-904.
8. van der Putten G.J., de Baat C., De Visschere L., Schols J. Poor oral health, a potential new geriatric syndrome. Gerodontology 2014, 31:17-24.
9. Murray Thomson W. Epidemiology of oral health conditions in older people. Gerodontology 2014, 31:9-16.
10. Mulligan R., Vanderlinde M.A. Treating the older adult dental patient: what are the issues of concern. J Calif Dent Assoc 2009, 37:804-810.
11. Wolff A., Fox P.C., Ship J.A., Atkinson J.C., Macynski A.A., Baum B.J. Oral mucosal status and major salivary gland function. Oral Surg Oral Med Oral Pathol 1990, 70:49-54.
12. Bergdahl M., Bergdahl J. Low unstimulated salivary flow and subjective oral dryness: association with medication, anxiety, depression, and stress. J Dent Res 2000, 79:1652-1658.
13. Kaplan I., Zuk-Paz L., Wolff A. Association between salivary flow rates, oral symptoms, and oral mucosal status. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008, 106:235-241.
14. Chen A., Wai Y., Lee L., Lake S., Woo S.B. Using the modified Schirmer test to measure mouth dryness: a preliminary study. J Am Dent Assoc 2005, 136:164-170.
15. Hopcraft M.S., Tan C. Xerostomia: an update for clinicians. Aust Dent J 2010, 55:238-244.
16. Whaley K., Williamson J., Chisholm D.M., Webb J., Mason D.K., Buchanan W.W. Sjogren's syndrome. I. Sicca components. Q J Med 1973, 42:279-304.
17. Napeñas J.J., Brennan M.T., Fox P.C. Diagnosis and treatment of xerostomia (dry mouth). Odontology 2009, 97:76-83.
18. Visvanathan V., Nix P. Managing the patient presenting with xerostomia: a review. Int J Clin Pract 2010, 64:404-407.
19. Pramanik R., Osailan S.M., Challacombe S.J., Urquhart D., Proctor G.B. Protein and mucin retention on oral mucosal surfaces in dry mouth patients. Eur J Oral Sci 2010, 118:245-253.
20. Furness S., Bryan G., McMillan R., Birchenough S., Worthington H.V. Interventions for the management of dry mouth: non-pharmacological interventions. Cochrane Database Syst Rev 2013, 9. CD009603s.
21. Humphrey S.P., Williamson R.T. A review of saliva: normal composition, flow, and function. J Prosthet Dent 2001, 85:162-169.
22. Mese H., Matsuo R. Salivary secretion, taste and hyposalivation. J Oral Rehabil 2007, 34:711-723.
23. Pedersen A.M., Bardow A., Jensen S.B., Nauntofte B. Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion. Oral Dis 2002, 8:117-129.
24. Fox P.C., Busch K.A., Baum B.J. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc 1987, 115:581-584.
25. Scully C. Drug effects on salivary glands: dry mouth. Oral Dis 2003, 9:165-176.
26. Baum B.J. Neurotransmitter control of secretion. J Dent Res 1987, 66:628-632.
27. Thaysen J.H., Thorn N.A., Schwartz I.L. Excretion of sodium, potassium, chloride and carbon dioxide in human parotid saliva. Am J Physiol 1954, 178:155-159.
28. Schubert M.M., Izutsu K.T. Iatrogenic causes of salivary gland dysfunction. J Dent Res 1987, 66:680-688.
29. Liu B., Dion M.R., Jurasic M.M., Gibson G., Jones J.A. Xerostomia and salivary hypofunction in vulnerable elders: prevalence and etiology. Oral Surg Oral Med Oral Pathol Oral Radiol 2012, 114:52-60.
30. Section 14: Xerostomia 2002, September, 115-117. Dental, Oral and Craniofacial Data Resource Center. Oral Health U.S., Bethesda, Maryland, http://drc.hhs.gov/report/pdfs/section14-xerostomia.pdf [accessed 03.10.14].
31. Smith C.H., Boland B., Daureeawoo Y., Donaldson E., Small K., Tuomainen J. Effect of aging on stimulated salivary flow in adults. J Am Geriatr Soc 2013, 61:805-808.
32. Plemons J.M., Al-Hashimi I., Marek C.L. Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 2014, 145:867-873. American Dental Association Council on Scientific Affairs.
33. Fenoll-Palomares C., Muñoz Montagud J.V., Sanchiz V., Herreros B., Hernández V., Mínguez M., et al. Unstimulated salivary flow rate, pH and buffer capacity of saliva in healthy volunteers. Rev Esp Enferm Dig 2004, 96:773-783.
34. Carlson G.W. The salivary glands. Embryology, anatomy, and surgical applications. Surg Clin North Am 2000, 80:261-273.
35. Sreebny L.M., Schwartz S.S. A reference guide to drugs and dry mouth - 2nd edition. Gerodontology 1997, 14:33-47.
36. Pedersen W., Schubert M., Izutsu K., Mersai T., Truelove E. Age-dependent decreases in human submandibular gland flow rates as measured under resting and post-stimulation conditions. J Dent Res 1985, 64:822-825.
37. Wolff A., Herscovici D., Rosenberg M. A simple technique for the determination of salivary gland hypofunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002, 94:175-178.
38. Vissink A., Jansma J., Spijkervet F.K., Burlage F.R., Coppes R.P. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 2003, 14:199-212.
39. Jensen S.B., Pedersen A.M., Reibel J., Nauntofte B. Xerostomia and hypofunction of the salivary glands in cancer therapy. Support Care Cancer 2003, 11:207-225.
40. Tylenda C.A., Ship J.A., Fox P.C., Baum B.J. Evaluation of submandibular salivary flow rate in different age groups. J Dent Res 1988, 67:1225-1228.
41. Ship J.A., Fox P.C., Baum B.J. How much saliva is enough? 'Normal' function defined. J Am Dent Assoc 1991, 122:63-69.
42. Heft M.W., Baum B.J. Unstimulated and stimulated parotid salivary flow rate in individuals of different ages. J Dent Res 1984, 63:1182-1185.
43. Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res 1987, 66:648-653.
44. Nederfors T., Isaksson R., Mornstad H., Dahlof C. Prevalence of perceived symptoms of dry mouth in an adult Swedish population - relation to age, sex and pharmacotherapy. Commun Dent Oral Epidemiol 1997, 25:211-216.
45. Wick J.Y. Xerostomia: causes and treatment. Consult Pharm 2007, 22:985-992.
46. Proctor G.B., Carpenter G.H. Regulation of salivary gland function by autonomic nerves. Auton Neurosci 2007, 133:3-18.
47. Thomson W.M. Issues in the epidemiological investigation of dry mouth. Gerodontology 2005, 22:65-76.
48. Thomson W.M. Measuring change in dry-mouth symptoms over time using the Xerostomia Inventory. Gerodontology 2007, 24:30-35.
49. Sasportas L.S., Hosford D.N., Sodini M.A., Waters D.J., Zambricki E.A., Barral J.K., et al. Cost-effectiveness landscape analysis of treatments addressing xerostomia in patients receiving head and neck radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol 2013, 116:e37-e51.
50. Thomson W.M., Chalmers J.M., Spencer A.J., Williams S.M. The Xerostomia Inventory: a multi-item approach to measuring dry mouth. Community Dent Health 1999, 16(1):12-17.
51. Navazesh M., Kumar S.K. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc 2008, 139:35S-40S. University of Southern California School of Dentistry.
52. Wolff A., Begleiter A., Moskona D. A novel system of human submandibular/sublingual saliva collection. J Dent Res 1997, 76:1782-1786.
53. Fox P.C., van der Ven P.F., Sonies B.C., Weiffenbach J.M., Baum B.J. Xerostomia: evaluation of a symptom with increasing significance. J Am Dent Assoc 1985, 110:519-525.
54. Ogami K., Sakurai K., Ando T. A method of measuring salivary flow rate in the lower labial mucosal region. J Oral Rehabil 2004, 31:861-865.
55. Smith R.G., Burtner A.P. Oral side-effects of the most frequently prescribed drugs. Spec Care Dentist 1994, 14:96-102.
56. Haga H.-J., Hulthen B., Bolstad Al., Ulvestad E., Jonsson R. Reliability and sensitivity of diagnostic tests for primary Sjogren's syndrome. J Rheumatol 1999, 26:604-608.
57. Spolarich A.E. Risk management strategies for reducing oral adverse drug events. J Evid Based Dent Pract 2014, 14(Suppl.):87-94.
58. Porter S.R., Scully C., Hegarty A.M. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004, 97:28-46.
59. Wm.Wrigley Jr.Co. Search for drugs that may cause dry mouth 2001, November, Available from: http://www.drymouth.info/practitioner/SearchForDrugs.asp [accessed 03.10.14].
60. Guggenheimer J., Moore P.A. Xerostomia: etiology, recognition and treatment. J Am Dent Assoc 2003, 134:61-69.
61. Gilbert G.H., Heft M.W., Duncan R.P. Mouth dryness as reported by older Floridians. Community Dent Oral Epidemiol 1993, 21:390-397.
62. Thomson W.M., Brown R.H., Williams S.M. Medication and perception of dry mouth in a population of institutionalized elderly people. N Z Med J 1993, 106:219-221.
63. Närhi T.O., Meurman J.H., Ainamo A. Xerostomia and hyposalivation: causes, consequences and treatment in the elderly. Drugs Aging 1999, 15:103-116.
64. Tschoppe P., Wolgin M., Pischon N., Kielbassa A.M. Etiologic factors of hyposalivation and consequences for oral health. Quintessence Int 2010, 41:321-333.
65. Peri Y., Agmon-Levin N., Theodor E., Shoenfeld Y. Sjögren's syndrome, the old and the new. Best Pract Res Clin Rheumatol 2012, 26:105-117.
66. Mulligan R., Navazesh M., Komaroff E., Greenspan D., Redford M., Alves M., et al. Salivary gland disease in human immunodeficiency virus-positive women from the WIHS study. Women's Interagency HIV Study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000, 89:702-709.
67. Kałuzny J., Wierzbicka M., Nogala H., Milecki P., Kopeć T. Radiotherapy induced xerostomia: mechanisms, diagnostics, prevention and treatment - evidence based up to 2013. Otolaryngol Pol 2014, 68:1-14.
68. Cho M.A., Ko J.Y., Kim Y.K., Kho H.S. Salivary flow rate and clinical characteristics of patients with xerostomia according to its aetiology. J Oral Rehabil 2010, 37:185-193.
69. Jensen S.B., Pedersen A.M., Vissink A., Andersen E., Brown C.G., Davies A.N., et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer 2010, 18:1039-1060.
70. Lovelace T.L., Fox N.F., Sood A.J., Nguyen S.A., Day T.A. Management of radiotherapy-induced salivary hypofunction and consequent xerostomia in patients with oral or head and neck cancer: meta-analysis and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol 2014, 117:595-607.
71. Kielbassa A.M., Hinkelbein W., Hellwig E., Meyer-Lückel H. Radiation-related damage to dentition. Lancet Oncol 2006, 7:326-335.
72. Kenney W.L., Chiu P. Influence of age on thirst and fluid intake. Med Sci Sports Exerc 2001, 33:1524-1532.
73. Wolff A., Fox P.C., Porter S., Konttinen Y.T. Established and novel approaches for the management of hyposalivation and xerostomia. Curr Pharm Des 2012, 18:5515-5521.
74. Furness S., Worthington H.V., Bryan G., Birchenough S., McMillan R. Interventions for the management of dry mouth: topical therapies. Cochrane Database Syst Rev 2011, 12. CD008934.
75. Weyant R.J., Tracy S.L., Anselmo T.T., Beltrán-Aguilar E.D., Donly K.J., Frese W.A., et al. Topical fluoride for caries prevention: executive summary of the updated clinical recommendations and supporting systematic review. J Am Dent Assoc 2013, 144:1279-1291.
76. Wong R.K., James J.L., Sagar S., Wyatt G., Nguyen-Tân P.F., Singh A.K., et al. Phase 2 results from Radiation Therapy Oncology Group Study 0537: a phase 2/3 study comparing acupuncture-like transcutaneous electrical nerve stimulation versus pilocarpine in treating early radiation-induced xerostomia. Cancer 2012, 118:4244-4252.
77. Cho J.H., Chung W.K., Kang W., Choi S.M., Cho C.K., Son C.G. Manual acupuncture improved quality of life in cancer patients with radiation-induced xerostomia. J Altern Complement Med 2008, 14:523-526.
78. Teguh D.N., Levendag P.C., Noever I., Voet P., van der Est H., van Rooij P., et al. Early hyperbaric oxygen therapy for reducing radiotherapy side effects: early results of a randomized trial in oropharyngeal and nasopharyngeal cancer. Int J Radiat Oncol Biol Phys 2009, 75:711-716.
79. Lončar B., Stipetić M.M., Baričević M., Risović D. The effect of low-level laser therapy on salivary glands in patients with xerostomia. Photomed Laser Surg 2011, 29:171-175.
80. Kam M.K., Leung S.F., Zee B., Chau R.M., Suen J.J., Mo F., et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007, 25:4873-4879.
81. Nutting C.M., Morden J.P., Harrington K.J., Urbano T.G., Bhide S.A., Clark C., et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomized controlled trial. Lancet Oncol 2011, 12:127-136.
82. Eisbruch A. Amifostine in the treatment of head and neck cancer: intravenous administration, subcutaneous administration, or none of the above. J Clin Oncol 2011, 29:119-121.
83. Seikaly H., Jha N., McGaw T., Coulter L., Liu R., Oldring D. Submandibular gland transfer: a new method of preventing radiation-induced xerostomia. Laryngoscope 2001, 111:347-352.
84. Frost P.M., Shirlaw P.J., Walter J.D., Challacombe S.J. Patient preferences in a preliminary study comparing an intra-oral lubricating device with the usual dry mouth lubricating methods. Br Dent J 2002, 193:403-408.
85. Lombaert I.M., Brunsting J.F., Wierenga P.K., Kampinga H.H., de Haan G., Coppes R.P. Keratinocyte growth factor prevents radiation damage to salivary glands by expansion of the stem/progenitor pool. Stem Cells 2008, 26:2595-2601.
86. Limesand K.H., Avila J.L., Victory K., Chang H.H., Shin Y.J., Grundmann O., et al. Insulin-like growth factor-1 preserves salivary gland function after fractionated radiation. Int J Radiat Oncol Biol Phys 2010, 78:579-586.
87. Teymoortash A., Müller F., Juricko J., Bieker M., Mandic R., Librizzi D., et al. Botulinum toxin prevents radiotherapy-induced salivary gland damage. Oral Oncol 2009, 45:737-739.
88. Vitolo J.M., Cotrim A.P., Sowers A.L., Russo A., Wellner R.B., Pillemer S.R., et al. The stable nitroxide tempol facilitates salivary gland protection during head and neck irradiation in a mouse model. Clin Cancer Res 2004, 10:1807-1812.
89. Ogawa M., Oshima M., Imamura A., Sekine Y., Ishida K., Yamashita K., et al. Functional salivary gland regeneration by transplantation of a bioengineered organ germ. Nat Commun 2013, 4:2498.
90. Kleiner S.M. Water: an essential but overlooked nutrient. J Am Diet Assoc 1999, 99:200-206.